Author

Bo Liao

Hainan Normal UniversityORCID 0000-0002-3383-5691Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Bo Liao1 paper · University of Ottawa

Biology Disciplines

Click to filter author papers

Bioinformatics· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Jibo Lu· 1 shared Keqin LiiD· 1 shared Liwei Liu· 1 shared Qi ZhangiD· 1 shared Shengli ZhangiD· 1 shared Xin QianiD· 1 shared Xing LiiD· 1 shared Xinguo LuiD· 1 shared

Activity by Year

2017-2023 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Jibo Lu

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsbioRxivPreprintSep 19, 2023

MMD-DTA: A multi-modal deep learning framework for drug-target binding affinity and binding region prediction

Liwei Liu, Qi Zhang, Yuxiao Wei…·Bo Liao

MMD-DTA predicts drug-target binding affinity and regions using a multi-modal deep learning framework, outperforming existing models and showing strong generalization.

2 citations

deep learningdrug response / drug discovery

𝕏 PostBluesky

BioinformaticsScientific ReportsPeer-reviewedNov 17, 2017

Driver Pattern Identification Over The Gene Co-Expression Of Drug Response In Ovarian Cancer By Integrating High Throughput Genomics Data

Xinguo Lu, Jibo Lu, Bo Liao…·Keqin Li

The paper identifies driver patterns in ovarian cancer drug response by integrating genomics data and analyzing gene co-expression and mutation networks.

29 citations

humanbulk RNA-seq

𝕏 PostBluesky